News

Search:
 Search

Latest News | 13 May 2013

Opening the Black Box: FDA Plans Study of DTC Advertising and Use of Composite Scores

0 Likes

The US Food and Drug Administration (FDA) has announced that it plans to move forward with a proposed study on direct-to-consumer (DTC) advertising first announced in August 2012 regarding the use of Read More...


Latest News | 13 May 2013

In Shift, FDA Denies Endo Petition to Ban Generic Painkiller, Slamming Citizen Petition's Use of Data

0 Likes

In a surprising move, the US Food and Drug Administration (FDA) on 10 May 2013 announced that it would permit generic competition to Endo Pharmaceuticals' generic pain pill Opana ER (oxymorphone Read More...


Latest News | 13 May 2013

Regulatory Reconnaissance (13 May 2013)

0 Likes

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US Did FDA Make a Huge Blunder Approving Merck’s Liptruzet? (MPT) (Forbes) (Pharmalot) (Counter: Read More...


Latest News | 10 May 2013

Five in Focus | FDA Reaches out to Industry for 510(k)s and Generics, EMA Limits Phthalates

0 Likes

Hello and welcome to a new  edition of Five in Focus, our Friday recap of the five most important, interesting, riveting or ground-breaking stories of the week.FDA Reaches out to Industry for Help as Read More...


Latest News | 10 May 2013

GSK's new COPD Therapy Wins FDA Approval

0 Likes

The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta (fluticasone furoate and vilanterol inhalation powder), just Read More...


Latest News | 10 May 2013

Judge Demolishes FDA's Plan B Appeal, Claims Agency Actions Undermining Public Confidence

0 Likes

In a scathing ruling issued on 10 May 2013, US District Court Judge Edward Korman has ordered the US Food and Drug Administration (FDA) to approve Teva Women's Health's citizen petition to approve its Read More...


Latest News | 10 May 2013

Woodcock: FDA Isn't Fully Aware of Compounding Problem's Scope

0 Likes

When it comes to pharmaceutical compounding, the US Food and Drug Administration (FDA) knows it has a significant problem on its hands. But as Janet Woodcock, director of the Center for Drug Read More...


Latest News | 10 May 2013

FDA Adopts Expedited Blood Donation Screening Standard

0 Likes

The US Food and Drug Administration (FDA) has released a final guidance document that it says is intended to expedite the donation of blood and plasma for frequent donors.BackgroundThe final guidance, Read More...


Latest News | 10 May 2013

Regulatory Reconnaissance (10 May 2013)

0 Likes

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.In Focus: US FDA Begins Gearing up to Hire Huge Number of New Employees to Meet GDUFA Targets (FDA) J&J Read More...


Latest News | 9 May 2013

Legislators Fire off Letters to FDA, Industry Seeking Information about 'Illegal' Supplement

0 Likes

The US Food and Drug Administration (FDA) often finds itself in the firing line of US legislators. The reasons vary—unsafe drugs, a deficient supply chain, too much regulatory activity, too little Read More...


1 ... 4 5 6 7 8 9 10 11 12 13 ... 230
RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

New Regulatory Focus Apps for iPad and iPhone